Virgini Vanessa S, Rodondi Nicolas, Cawthon Peggy M, Harrison Stephanie Litwack, Hoffman Andrew R, Orwoll Eric S, Ensrud Kristine E, Bauer Douglas C
Department of Internal Medicine (V.S.V.), University Hospital of Zürich, 8091 Zürich, Switzerland; Department of General Internal Medicine (N.R.), Inselspital, University Hospital of Bern, 3010 Bern, Switzerland; California Pacific Medical Center Research Institute (L.H.), San Francisco, California 94107; Stanford University Medical School (A.R.H.), Palo Alto, California 94305; Bone and Mineral Unit (E.S.O.), Oregon Health & Science University, Portland, Oregon 97239; Department of Medicine (K.E.E.) and Division of Epidemiology and Community Health (K.E.E.), University of Minnesota, Minneapolis, Minnesota 55455; Center for Chronic Disease Outcomes Research (K.E.E.), Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota 55417; and Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California 94143.
J Clin Endocrinol Metab. 2015 Dec;100(12):4524-32. doi: 10.1210/jc.2015-3191. Epub 2015 Oct 23.
Both subclinical thyroid dysfunction and frailty are common among older individuals, but data on the relationship between these 2 conditions are conflicting.
The purpose of this study was to assess the cross-sectional and prospective associations between subclinical thyroid dysfunction and frailty and the 5 frailty subdomains (sarcopenia, weakness, slowness, exhaustion, and low activity).
The Osteoporotic Fractures in Men Study is a prospective cohort study.
Men older than 65 years (n = 1455) were classified into 3 groups of thyroid status: subclinical hyperthyroidism (n = 26, 1.8%), subclinical hypothyroidism (n = 102, 7.0%), and euthyroidism (n = 1327, 91.2%).
Frailty was defined using a slightly modified Cardiovascular Health Study Index: men with 3 or more criteria were considered frail, men with 1 to 2 criteria were considered intermediately frail, and men with no criteria were considered robust. We assessed the cross-sectional relationship between baseline thyroid function and the 3 categories of frailty status (robust/intermediate/frail) as well as the prospective association between baseline thyroid function and subsequent frailty status and mortality after a 5-year follow-up.
At baseline, compared with euthyroid participants, men with subclinical hyperthyroidism had an increased likelihood of greater frailty status (adjusted odds ratio, 2.48; 95% confidence interval, 1.15-5.34), particularly among men aged <74 years at baseline (odds ratio for frailty, 3.63; 95% confidence interval, 1.21-10.88). After 5 years of follow-up, baseline subclinical hypothyroidism and hyperthyroidism were not consistently associated with overall frailty status or frailty components.
Among community-dwelling older men, subclinical hyperthyroidism, but not subclinical hypothyroidism, is associated with increased odds of prevalent but not incident frailty.
亚临床甲状腺功能障碍和衰弱在老年人中都很常见,但关于这两种情况之间关系的数据相互矛盾。
本研究的目的是评估亚临床甲状腺功能障碍与衰弱以及5个衰弱亚领域(肌肉减少症、虚弱、行动迟缓、疲惫和低活动量)之间的横断面和前瞻性关联。
男性骨质疏松性骨折研究是一项前瞻性队列研究。
65岁以上男性(n = 1455)被分为3组甲状腺状态:亚临床甲状腺功能亢进(n = 26,1.8%)、亚临床甲状腺功能减退(n = 102,7.0%)和甲状腺功能正常(n = 1327,91.2%)。
使用经过轻微修改的心血管健康研究指数定义衰弱:有3项或更多标准的男性被认为衰弱,有1至2项标准的男性被认为中度衰弱,没有标准的男性被认为强健。我们评估了基线甲状腺功能与3类衰弱状态(强健/中度/衰弱)之间的横断面关系,以及基线甲状腺功能与5年随访后的后续衰弱状态和死亡率之间的前瞻性关联。
在基线时,与甲状腺功能正常的参与者相比,亚临床甲状腺功能亢进的男性有更高衰弱状态的可能性增加(调整后的优势比,2.48;95%置信区间,1.15 - 5.34),特别是在基线年龄<74岁的男性中(衰弱的优势比,3.63;95%置信区间,1.21 - 10.88)。经过5年的随访,基线亚临床甲状腺功能减退和亢进与总体衰弱状态或衰弱成分没有一致的关联。
在社区居住的老年男性中,亚临床甲状腺功能亢进而非亚临床甲状腺功能减退与现患而非新发衰弱的几率增加有关。